The French biotechnology firm aims to develop therapies for various neurological conditions using its non-replicating HSV-1 vector technology.

Gene therapy is at the cutting edge of medicine, with exciting new products being developed and used to treat a wide variety ...

In the early 1990s, researchers set out to harness viruses for gene therapy applications ... In perhaps the best known example, lentivirus-based vectors were instrumental to the development ...

Biopharmas have been scaling back on AAV research for sometime now. Find out why and what's on the horizon for drug delivery ...

For example, by inserting a DNA sequence between ... However, this has proved challenging to achieve because the Cre gene in the vector is spontaneously expressed in the E. coli bacteria used ...

Improvements include a more efficient delivery vector and biomarkers ... factors that could make gene therapy safer, more customized and more predictable. For example, it would be useful to ...

The Gene Vector Core was awarded the Blue Flame Award. The award is given to scientists who have at least one plasmid deposited that has been distributed at least 100 times. The Gene Vector Core was ...

New breakthrough data from studies evaluating the vector (research code S01coAAV2) have been selected for presentation as a Late-Breaking Abstract at the 2025 American Society of Gene & Cell ...

I think agile software development is the perfect example of this approach ... I know firsthand how a misaligned gene vector can lead to ineffective therapies, just as misallocated business ...